Enterprise Financial Services Corp (EFSC)’s Achillion Pharmaceuticals ACHN Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-388	Closed	-$3K	–	1111
2016 Q3	$3K	Hold	388	–	–	﹤0.01%	839
2016 Q2	$3K	Sell	388 -103	-21%	-$884	﹤0.01%	812
2016 Q1	$4K	Buy	+491	New	+$3.6K	﹤0.01%	768
2015 Q2	–	Sell	-209	Closed	-$2K	–	1260
2015 Q1	$2K	Hold	209	–	–	﹤0.01%	1060
2014 Q4	$3K	Buy	+209	New	+$2.55K	﹤0.01%	962

Other funds holding ACHN

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s ACHN Position: Q4 2016 in Review

Enterprise Financial Services Corp (EFSC) sold out of Achillion Pharmaceuticals (ACHN) in Q4 2016, closing a stake of 388 shares — an estimated $3K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in ACHN in Q4 2014 and held it in 5 quarters. The position peaked at $4K in Q1 2016. 140 funds tracked by Wall St. Rank hold ACHN as of Q4 2016.

Enterprise Financial Services Corp (EFSC) reported no remaining Achillion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Enterprise Financial Services Corp (EFSC) sold 388 Achillion Pharmaceuticals shares in Q4 2016, an estimated $3K.
Enterprise Financial Services Corp (EFSC) first reported a position in Achillion Pharmaceuticals in Q4 2014 and held it in 5 quarters.
Enterprise Financial Services Corp (EFSC)'s Achillion Pharmaceuticals position peaked at $4K in Q1 2016.
140 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2016.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q4 2016, filed 26 Jan 2017.